Take­da to pull key hy­poparathy­roidism drug from the mar­ket af­ter years of man­u­fac­tur­ing woes

Take­da on Tues­day morn­ing made an an­nounce­ment that al­most 3,000 peo­ple with the rare dis­ease known as hy­poparathy­roidism were fear­ing.

Due to un­re­solved sup­ply is­sues …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER